Open AccessMedicine

A. Dasari, Chan Shen, D. Halperin, Bo Zhao, Shouhao Zhou, Ying Xu, T. Shih, James C. Yao

2017.10.1JAMA Oncology

DOI: 10.1001/jamaoncol.2017.0589

tlooto Summary

Survival for all NETs has improved over time, especially for distant-stage gastrointestinal NETs and pancreatic NETs in particular, reflecting improvement in therapies.

Abstract

Abstract is not available.

Citation format

DASARI, A., et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncology, 2017, 3: 1335–1342.